适应性体力活动计划对帕金森病的影响:一项随机对照研究 (APA-Park)
Carole Zanchet1, Céline Lambert2, Thibaut Boyer3
1Université Clermont Auvergne, IGCNC, CHU Clermont-Ferrand, Neurology Department, Clermont-Ferrand, France; Université Clermont Auvergne, laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques (AME2P), EA 3533, F-63000, Clermont-Ferrand, France.
Parkinsonism & related disorders
|March 15, 2025
概括
一个为期3个月的适应体力活动 (APA) 计划改善了帕金森病 (PD) 患者的运动症状. 然而,对于PD患者来说,这些好处在计划结束六个月后逐渐消失.
科学领域:
- 神经学 神经学
- 运动科学 运动科学
- 康复医学 康复医学 康复医学
背景情况:
- 帕金森病 (PD) 对适应性体力活动 (APA) 的研究缺乏标准化的方法和长期评估.
- 之前的研究还没有全面评估PD管理中的联合炼模式.
研究的目的:
- 评估3个月的APA计划对PD患者的运动症状,身体组成,心肺功能和代谢概况的直接和长期影响.
- 该计划结合了耐力,抵抗训练和拉伸.
主要方法:
- 一项受控试验随机将44名PD患者分配到APA计划组 (APA+组,n=22) 或对照组 (APA-组,n=22).
- 患者在基线,3个月 (M3) 和9个月 (M9) 评估了帕金森症状 (UPDRS-III),身体组成,心肺功能和代谢概况.
主要成果:
- 与APA-组相比,APA+组的UPDRS-III分数从基线到M3显著下降 (p=0.04).
- 在PD患者中,这些运动症状的改善在M9.9时没有持续.
- 在M3或M9的身体组成,代谢概况或心肺呼吸功能方面没有观察到任何显著的群体差异.
结论:
- 3个月的APA计划结合了耐力,抵抗训练和拉伸,有效地改善了PD患者的运动症状.
- 在PD患者中,对运动功能的积极影响在项目终止后的六个月后会减少.
相关概念视频
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


